ArticleCancer cell international2022

Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers.

Haixiang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.